The Challenges and Opportunities of lncRNAs in Ovarian Cancer Research and Clinical Use

Use this link to cite
http://hdl.handle.net/2183/25604Collections
- Investigación (FCS) [1292]
Metadata
Show full item recordTitle
The Challenges and Opportunities of lncRNAs in Ovarian Cancer Research and Clinical UseAuthor(s)
Date
2020-04-21Citation
Salamini-Montemurri, M., Lamas-Maceiras, M., Barreiro-Alonso, A., Vizoso-Vázquez, Á., Rodríguez-Belmonte, E., Quindós-Varela, M., & Cerdán, M. E. (2020). The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use. Cancers, 12(4), 1020. doi:10.3390/cancers12041020
Abstract
[Abstract] Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it tends to be detected late, when the disease has already spread, and prognosis is poor. In this review we aim to highlight the importance of long non-coding RNAs (lncRNAs) in diagnosis, prognosis and treatment choice, to make progress towards increasingly personalized medicine in this malignancy. We review the effects of lncRNAs associated with ovarian cancer in the context of cancer hallmarks. We also discuss the molecular mechanisms by which lncRNAs become involved in cellular physiology; the onset, development and progression of ovarian cancer; and lncRNAs’ regulatory mechanisms at the transcriptional, post-transcriptional and post-translational stages of gene expression. Finally, we compile a series of online resources useful for the study of lncRNAs, especially in the context of ovarian cancer. Future work required in the field is also discussed along with some concluding remarks.
Keywords
Diagnosis
Prognosis
Therapy
Molecular mechanisms
Bioinformatics tools
Prognosis
Therapy
Molecular mechanisms
Bioinformatics tools
Editor version
Rights
Atribución 4.0 Internacional
ISSN
2072-6694